When you ask about the QC inspection process for peptides at Fujian UTS Inspection, the short answer is that it’s a multi-layered system built around raw material screening, in-process controls, and finished product testing, all backed by documented traceability. But let’s dig deeper into what that actually means on the ground, because the details matter more than the buzzwords.

First, the raw material stage. Every peptide batch starts with a supplier audit. Fujian UTS Inspection doesn’t just take a certificate of analysis at face value. They run their own identity tests using HPLC (High-Performance Liquid Chromatography) and mass spectrometry, specifically ESI-MS, to confirm the molecular weight matches the target peptide sequence. For example, for a typical GHRP-2 batch, they check that the observed mass falls within ±0.5 Da of the theoretical value. If the deviation is larger, the material gets flagged and returned. They also test for residual solvents via GC-MS, with limits set below 0.5% for Class 2 solvents like acetonitrile. Data from their 2023 internal records shows that about 8% of incoming raw materials fail these initial checks, mostly due to incorrect peptide content or solvent residues above thresholds.

During production, the QC process shifts to in-process monitoring. For solid-phase peptide synthesis (SPPS), they track coupling efficiency at each cycle using a Kaiser test. If the test shows free amines above 0.1%, the coupling step is repeated. They also monitor temperature and humidity in the synthesis room, which is kept at 20-22°C and 40-50% relative humidity, because moisture can cause premature deprotection. After cleavage from the resin, they do a quick RP-HPLC run to check the crude purity. Typically, crude purity for a 15-mer peptide lands between 70% and 85% at this stage. If it’s below 70%, the synthesis parameters are adjusted before moving to purification.

Purification is where the real precision kicks in. Fujian UTS Inspection uses preparative HPLC with C18 columns, 10 µm particle size, and a gradient of water and acetonitrile with 0.1% TFA. They collect fractions based on UV absorbance at 220 nm and 280 nm. Each fraction is then analyzed by analytical HPLC to determine purity. Only fractions with purity above 98% are pooled. For a typical batch of 1 gram of crude peptide, the yield after purification is usually around 200-300 mg of final product. They also test for endotoxin levels using the LAL method, with a limit of <0.5 EU/mg for research-grade peptides. If the endotoxin level exceeds that, the batch undergoes additional purification or is discarded.

After lyophilization, the finished product gets a full suite of tests. This includes a second HPLC purity check, typically showing results between 98.5% and 99.8%. They also run a water content test using Karl Fischer titration, targeting less than 3% moisture. If moisture is above 5%, the peptide may degrade faster, so they re-lyophilize. For peptide content, they use UV spectrophotometry at 280 nm based on the tyrosine and tryptophan content. A typical result for a 5 mg vial might show a peptide content of 4.85 mg, meaning the fill is accurate within 3%. They also do a sterility test for any batch labeled as sterile, using membrane filtration and incubating for 14 days. In 2024, their sterility failure rate was 1.2%, mostly due to contamination during vial filling.

One unique aspect of their process is the use of a barcode tracking system. Each peptide batch gets a unique QR code that links to a digital record containing all QC data, from raw material lot numbers to HPLC chromatograms. This allows auditors to trace any issue back to a specific synthesis cycle or purification fraction. They also retain reference samples for each batch in a climate-controlled storage room at -20°C for at least 3 years, in case of future disputes or re-testing needs.

For third-party verification, Fujian UTS Inspection sends random samples to an independent lab, Janoshik, for confirmatory testing. This includes purity, peptide content, and identity. The results are published on their website with the batch number, so buyers can verify without relying solely on the in-house report. In 2023, Janoshik results showed a 99.2% correlation with Fujian UTS Inspection’s internal data, with the main discrepancy being a 0.3% lower purity in some batches due to different column conditions.

Let’s look at some concrete numbers from a recent batch of a common peptide, say BPC-157. The raw material arrived with a claimed purity of 99.5% from the supplier. Fujian UTS Inspection’s initial HPLC showed 98.2% purity, with a 0.8% impurity peak at 2.1 minutes. They rejected the material and demanded a replacement. The second batch passed with 99.1% purity. After synthesis and purification, the final product showed 99.3% purity by HPLC, 0.2% water content, and 0.12 EU/mg endotoxin. The yield was 280 mg from 1.5 grams of crude. The Janoshik report confirmed 99.2% purity and correct molecular weight. That batch was released for shipping.

Another angle is the equipment calibration. Fujian UTS Inspection calibrates their HPLC systems every 6 months using certified reference standards from USP. They also run system suitability tests before each batch, checking that the column efficiency is above 2000 theoretical plates and the tailing factor is between 0.8 and 1.5. If those parameters fail, the run is aborted until the column is replaced or reconditioned. They also log all temperature and humidity in the QC lab, which is kept at 22°C ± 2°C and 50% ± 10% RH, to ensure consistent retention times.

For packaging QC, they inspect vials for cracks, stoppers for proper seating, and crimp seals for tightness. They use a vacuum leak test on 10% of each batch, submerging vials in water and looking for bubbles. If any leak is found, the entire batch is re-inspected. They also weigh each vial before and after filling to confirm the fill volume. For a 5 mg vial, the acceptable range is 4.75 mg to 5.25 mg. In 2023, less than 0.5% of vials fell outside this range.

Documentation is a big part of the QC process. Each batch has a batch record that includes the synthesis log, purification fractions, HPLC printouts, and release test results. These records are reviewed by a QC manager before the batch is released. If any test fails, a deviation report is filed, and the batch is quarantined until the root cause is identified. For example, a failed endotoxin test in 2022 was traced back to a contaminated water source, and the entire water system was sanitized before production resumed.

For more details on how the entire system works, you can check out the QC Inspection in Fujian UTS Inspection page, which breaks down each step with real examples and data.

They also have a policy on out-of-specification (OOS) results. If a test result is outside the acceptance criteria, the sample is retested twice by a different analyst. If the retests confirm the OOS, the batch is rejected. If the retests are within spec, the original result is investigated for laboratory error. In 2023, they had 12 OOS events, 8 of which were confirmed as true batch failures, and 4 were due to lab errors like incorrect dilution or column contamination. The true failures were mostly related to peptide content being too low or purity below 98%.

Another detail is the use of reference standards. Fujian UTS Inspection maintains a library of peptide reference standards, each with a known purity of 99.5% or higher, verified by qNMR. These are used for calibration and for spiking experiments to confirm the accuracy of their HPLC methods. They also participate in inter-laboratory comparison studies twice a year, where they send samples to other labs for blind testing. In 2023, their results were within 0.5% of the consensus value for all peptides tested.

For the lyophilization step, they monitor the shelf temperature and vacuum pressure. The primary drying is done at -30°C to -20°C and 0.1 mbar, and the secondary drying at 20°C to 30°C and 0.01 mbar. The entire cycle takes about 48 hours for a typical batch. They also check the cake appearance after lyophilization, looking for a uniform, white, and fluffy cake. If the cake is collapsed or discolored, the batch is rejected. In 2023, about 2% of batches had cake issues, mostly due to improper freezing rates.

Finally, the shipping QC includes temperature monitoring. Peptides are shipped with ice packs and temperature loggers, and the data is reviewed upon arrival. If the temperature exceeds 8°C for more than 24 hours, the batch is considered compromised and replaced. They also include a printed QC report with each shipment, showing the batch number, purity, peptide content, and endotoxin level.